Target Identification

The right move at the right time can be transformational. In life sciences, the best opportunities lie at the intersection of technology, market, team, and timing. DeciBio can filter the signal from the noise, and identify the best investment targets for your company or fund.

Our Experts

Stephane Budel

Miguel Edwards

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

Clinical Diagnostics

MRD Monitoring Market Assessment and Strategy

A diagnostics player wanted to determine with indications / use cases to target and develop a product road map

Biomarker and Diagnostics Strategy

Go-to-Market Strategy

Market Landscaping and Sizing

Pharma & Biotech

Cell and Gene Therapy Services Landscape Assessment

A top-10 scientific service provider wanted to quantify the size of the CGT services market and understand trends within

No items found.

Financial Services

CDD on Novel Handheld Diagnostic Device Manufacturer

A global healthcare investment firm wanted to perform a commercial due diligence (CDD) prior to investment in a company producing a novel handheld diagnostic.

Voice-of-Customer Research

KOL Identification

Pricing Strategy

Revenue Projection

Due Diligence

Financial Services

PE-Backed Life Sciences Tools Platform Development

A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

Voice-of-Customer Research

Customer Segmentation

Pricing Strategy

Due Diligence

Competitive Analysis

Clinical Diagnostics

Low-Throughput Molecular Diagnostic Testing Landscape Assessment

A leading diagnostic company wanted an assessment of the future market landscape for low-throughput (LT) molecular diagnostic (MDx) testing to develop a long-term platform strategy to address the future needs of this market

Voice-of-Customer Research

Competitive Analysis

Customer Segmentation

Clinical Diagnostics

Carrier Screening Landscape Assessment

A leading diagnostics player wanted an assessment of the current and future carrier screening landscape, primarily in the U.S., to guide their product development strategy

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help